Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 4.4 | 2.2 | 1.0 | 0.1 | 0.1 | 0.0 |
| Revenue growth | 101.5% | 120.3% | 939.9% | -25.2% | | |
| Cost of goods sold | 17.1 | 8.3 | 2.9 | 0.1 | 0.1 | 0.0 |
| Gross profit | -12.8 | -6.1 | -1.9 | 0.0 | 0.0 | 0.0 |
| Gross margin | -291.0% | -279.1% | -194.7% | -34.2% | 38.2% | |
| Sales and marketing | 7.0 | 2.2 | 1.0 | 1.6 | 0.8 | 0.5 |
| Research and development | | | 6.0 | 3.8 | 1.5 | 1.0 |
| General and administrative | 12.9 | 6.1 | 5.5 | 5.6 | 1.1 | 0.5 |
| EBIT | -32.7 | -14.4 | -14.5 | -11.0 | -3.3 | -1.9 |
| EBIT margin | -745.8% | -661.9% | -1463.3% | -11602.4% | -2593.7% | |
| Pre-tax income | -47.6 | -18.1 | -15.3 | -11.1 | -3.3 | -1.9 |
| Income taxes | 2.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -50.5 | -18.1 | -15.3 | -11.1 | -3.3 | -1.9 |
| Net margin | -1151.3% | -832.6% | -1553.0% | -11633.1% | -2610.2% | |
| |
| Diluted EPS | ($1.38) | ($0.63) | ($0.85) | ($0.70) | ($0.24) | ($0.19) |
| Shares outstanding (diluted) | 36.7 | 28.6 | 18.1 | 15.8 | 13.6 | 10.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|